NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2015 to Q4 2025

Type / Class
Equity / NYLI FTSE INTERN
Symbol
HFXI
Price per share
$32.45
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
27,457,140
Total reported value
$851,670,372
% of total 13F portfolios
0%
Share change
+206,001
Value change
+$6,739,442
Number of holders
80
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 80 institutional investors reported holding 27,457,140 shares of NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI).

Institutional Holders of NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 267,999 $8,889,707 +$174,275 $32.45 3
2025 Q3 27,457,140 $851,670,372 +$6,739,442 $31.01 80
2025 Q2 26,750,690 $788,444,661 -$47,372,337 $29.47 80
2025 Q1 28,561,319 $786,070,487 +$122,540,163 $27.52 79
2024 Q4 25,682,058 $671,721,059 +$54,321,632 $26.06 74
2024 Q3 23,085,357 $636,509,868 +$143,821,363 $27.64 68
2024 Q2 17,828,280 $476,005,549 +$20,514,402 $26.70 66
2024 Q1 17,006,586 $456,208,352 +$15,419,107 $26.83 60
2023 Q4 13,645,009 $339,339,883 +$12,686,845 $24.87 56
2023 Q3 14,607,188 $337,996,972 +$42,789,177 $23.14 44
2023 Q2 12,879,982 $308,651,604 +$28,481,708 $23.96 43
2023 Q1 11,698,046 $269,870,888 +$2,450,449 $23.07 34
2022 Q4 11,541,196 $246,407,208 +$35,925,492 $21.35 32
2022 Q3 9,846,147 $189,724,000 +$6,253,952 $19.27 32
2022 Q2 9,497,217 $198,310,000 -$24,185,836 $20.88 33
2022 Q1 10,638,311 $250,991,000 -$12,681,883 $23.60 35
2021 Q4 11,131,755 $278,852,000 -$4,886,561 $25.05 34
2021 Q3 11,327,386 $276,735,240 +$4,223,104 $24.43 37
2021 Q2 11,156,130 $276,323,000 -$806,984 $24.77 30
2021 Q1 11,194,885 $267,555,000 -$5,597,026 $23.90 30
2020 Q4 11,416,347 $258,956,000 -$7,618,579 $22.68 30
2020 Q3 11,752,833 $233,772,000 +$5,034,863 $19.89 27
2020 Q2 11,499,288 $222,585,000 -$29,073,422 $19.36 31
2020 Q1 12,344,831 $207,434,000 +$38,411,683 $16.80 33
2019 Q4 10,756,491 $225,753,000 +$53,333,552 $21.72 38
2019 Q3 8,148,003 $1,079,814 -$5,643,796 $0.02 28
2019 Q2 12,095,032 $246,253,000 -$46,561,507 $20.36 26
2019 Q1 14,381,883 $287,789,000 -$62,859,940 $20.01 22
2018 Q4 17,568,951 $319,224,000 -$106,243,621 $18.17 23
2018 Q3 23,408,214 $493,443,000 -$51,508,379 $21.08 21
2018 Q2 25,852,679 $540,570,000 -$467,770,078 $20.91 20
2018 Q1 48,070,485 $1,011,886,000 +$632,113,552 $21.05 24
2017 Q4 18,041,088 $390,605,000 +$89,855,974 $21.65 21
2017 Q3 13,909,107 $289,033,000 -$10,531,057 $20.78 18
2017 Q2 14,416,171 $290,349,000 +$90,488,362 $20.14 15
2017 Q1 9,888,099 $190,949,000 +$2,806,297 $19.31 14
2016 Q4 8,421,959 $152,687,000 -$136,306 $18.13 10
2016 Q3 8,429,418 $153,669,000 +$25,495,950 $18.23 10
2016 Q2 7,031,646 $120,670,000 +$58,761,243 $17.16 11
2016 Q1 2,235,749 $38,862,000 +$4,004,429 $17.38 8
2015 Q4 3,312,694 $60,228,000 +$25,997,472 $18.18 8
2015 Q3 1,882,697 $33,076,000 +$33,076,020 $17.56 5